"Urologic Surgeons of Washington has been providing the highest quality Urologic care in the Washington DC area for over 45 years. Dr. Jason Engel strives to achieve the highest level of patient care in the office and operating room setting. With locations in downtown D.C. and Chevy Chase, MD, patients are able to easily access their provider. Additionally, the practice is an integral part of the Department of Urology at George Washington University Hospital as well as Sibley Memorial Hospital. With access to both academic and private institutions, cutting edge Urologic care can be delivered to general and much more complex Urologic conditions."

During the past decade, Urologic Surgeons of Washington conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Urologic Surgeons of Washington" #1 collaborator was "Duke Clinical Research Institute" with 1 trials as a collaborator and "Memorial Sloan Kettering Cancer Center" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Urologic Surgeons of Washington" are "Bladder Cancer" (1 trials), "Castration-resistant Prostate Cancer" (1 trials), "Prostate Cancer" (1 trials), "Prostate Cancer Metastatic" (1 trials) and "Urinary Incontinence" (1 trials). Many other conditions were trialed in "Urologic Surgeons of Washington" in a lesser frequency.

Most popular intervention types in "Urologic Surgeons of Washington" are "Drug" (4 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Apaziquone" (1 trials), "Degarelix" (1 trials), "Enzalutamide" (1 trials) and "HC-1119" (1 trials). Other intervention names were less common.

The vast majority of trials in "Urologic Surgeons of Washington" are 3 trials for "Male" genders and 1 trials for "All" genders.

Currently, there are NaN active trials in "Urologic Surgeons of Washington". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Urologic Surgeons of Washington, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Urologic Surgeons of Washington, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".